🔥 TRENDING RaGa's Economic Blueprint Faces Sharp... PM Modi Highlights Rapid Expansion of... Global Media Scrutinizes India's Clima... Russia's Trenin: India has a real chan... India Rethinks Neighbourhood Diplomacy... India Face Windy Wellington in New Era...
19 Nov 2026•
ગુજરાતી मराठी ਪੰਜਾਬੀ বাংলা
Study: India's CSR funds miss health gaps, favor cancer over heart disease
📷 Image: The Hindu (via NewsData)
Health

Study: India's CSR funds miss health gaps, favor cancer over heart disease

✍️ The Hindu 🗓 19 Nov 2026, 05:48 AM 👁 22
Share: 💬 WhatsApp 📘 Facebook 𝕏 Post

A new report highlights that Indian Corporate Social Responsibility spending is misaligned with health needs, directing 62% of NCD funds to cancer while cardiovascular diseases, which cause over half of NCD deaths, receive only 12%.

A recent study by a global impact consulting firm based in the city has revealed significant gaps in India's Corporate Social Responsibility (CSR) spending regarding public health. The report indicates that while non-communicable diseases (NCDs) are a major health crisis, corporate funding does not align with the actual burden of these diseases.

The data shows that NCDs now account for 60% of all deaths in India, a sharp increase from 45% recorded between 2004 and 2006. Despite this rising mortality rate, the allocation of CSR funds for NCDs remains skewed. Approximately 62% of the identifiable funding for these diseases is directed towards cancer treatment and awareness.

In contrast, cardiovascular diseases, which are responsible for more than half of all NCD-related deaths, receive only around 12% of the available CSR funding. This disparity suggests a misalignment between corporate health initiatives and the most critical health needs of the Indian population.

The report also points out gaps in other essential areas such as water security and innovation, suggesting that CSR efforts need to be more strategically targeted to address the most pressing public health and social challenges in the country.
📲Get App